Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-045895
Filing Date
2024-11-14
Accepted
2024-11-14 16:16:14
Documents
76
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 2750464
2 ex31-1.htm EX-31.1 12019
3 ex31-2.htm EX-31.2 12087
4 ex32-1.htm EX-32.1 7766
5 ex32-2.htm EX-32.2 7797
6 form10-q_001.jpg GRAPHIC 6075
  Complete submission text file 0001493152-24-045895.txt   10763615

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE mgrx-20240930.xsd EX-101.SCH 54386
8 XBRL CALCULATION FILE mgrx-20240930_cal.xml EX-101.CAL 62592
9 XBRL DEFINITION FILE mgrx-20240930_def.xml EX-101.DEF 309842
10 XBRL LABEL FILE mgrx-20240930_lab.xml EX-101.LAB 493425
11 XBRL PRESENTATION FILE mgrx-20240930_pre.xml EX-101.PRE 423362
79 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1672518
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

EIN.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41615 | Film No.: 241462586
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 03 Life Sciences)